ConductScience.org, home

Paper40524980

Triphenylphosphine-Based Mitochondrial Targeting Nanocarriers: Advancing Cancer Therapy.

Ali MS and 3 others. Clin Pharmacol, 2025. Cited by 14 papers, by iCite.

Cite this record

ConductScience Library. Triphenylphosphine-Based Mitochondrial Targeting Nanocarriers: Advancing Cancer Therapy. Papers, record 40524980. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40524980

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Triphenylphosphine-Based Mitochondrial Targeting Nanocarriers: Advancing Cancer Therapy.
PubMed
Journal
Clin Pharmacol
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
14
iCite
Relative citation ratio, by iCite
4.27, provisional
iCite
Revised in PubMed
2025-06-20
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ali MSMohd Shoab
2Gowda BHJB H Jaswanth
3Shukla RRahulhttps://orcid.org/0000-0002-4864-0133
4Kesharwani PPrashanthttps://orcid.org/0000-0002-0890-769X

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References151

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132337527Multifunctional sonosensitizers in sonodynamic cancer therapy.Chem Soc Rev2020https://conductscience.org/library/papers/32337527PubMed
210469134Selective targeting of an antioxidant to mitochondria.Eur J Biochem1999https://conductscience.org/library/papers/10469134PubMed
328236692Synthesis and characterization of folate decorated albumin bio-conjugate nanoparticles loaded with a synthetic curcumin difluorinated analogue.J Colloid Interface Sci2017https://conductscience.org/library/papers/28236692PubMed
433329007Formulation and Development of Transferrin Targeted Solid Lipid Nanoparticles for Breast Cancer Therapy.Front Pharmacol2020https://conductscience.org/library/papers/33329007PubMed
530048028Chemodynamic Therapy: Tumour Microenvironment-Mediated Fenton and Fenton-like Reactions.Angew Chem Int Ed Engl2019https://conductscience.org/library/papers/30048028PubMed
636978874Rosemary (Rosmarinus officinalis L.) Glycolic Extract Protects Liver Mitochondria from Oxidative Damage and Prevents Acetaminophen-Induced Hepatotoxicity.Antioxidants (Basel)2023https://conductscience.org/library/papers/36978874PubMed
716638611Mitochondrial dysfunction and caspase activation in rat cortical neurons treated with cocaine or amphetamine.Brain Res2006https://conductscience.org/library/papers/16638611PubMed
830144423Targeting mitochondria in cancer: current concepts and immunotherapy approaches.Transl Res2018https://conductscience.org/library/papers/30144423PubMed
930173542Mitochondrial-targeted penetrating peptide delivery for cancer therapy.Expert Opin Drug Deliv2018https://conductscience.org/library/papers/30173542PubMed
1032020724Triphenylphosphonium (TPP)-Based Antioxidants: A New Perspective on Antioxidant Design.ChemMedChem2020https://conductscience.org/library/papers/32020724PubMed
1134943772A Mitochondria-Penetrating Peptide Exerts Potent Anti-Plasmodium Activity and Localizes at Parasites' Mitochondria.Antibiotics (Basel)2021https://conductscience.org/library/papers/34943772PubMed
1235644289Recent trends in the application of nanoparticles in cancer therapy: The involvement of oxidative stress.J Control Release2022https://conductscience.org/library/papers/35644289PubMed
1328654243Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications.Chem Rev2017https://conductscience.org/library/papers/28654243PubMed
1430566834Mitochondria Targeting and Destabilizing Hyaluronic Acid Derivative-Based Nanoparticles for the Delivery of Lapatinib to Triple-Negative Breast Cancer.Biomacromolecules2019https://conductscience.org/library/papers/30566834PubMed
1510751361Openings between defective endothelial cells explain tumor vessel leakiness.Am J Pathol2000https://conductscience.org/library/papers/10751361PubMed
1626567518In Vivo Antitumor Activity of Folate-Conjugated Cholic Acid-Polyethylenimine Micelles for the Codelivery of Doxorubicin and siRNA to Colorectal Adenocarcinomas.Mol Pharm2015https://conductscience.org/library/papers/26567518PubMed
1721663778Targeted drug delivery to tumors: myths, reality and possibility.J Control Release2011https://conductscience.org/library/papers/21663778PubMed
1837451568Nanotechnology-empowered strategies in treatment of skin cancer.Environ Res2023https://conductscience.org/library/papers/37451568PubMed
1935994990Polymeric nanoparticles-siRNA as an emerging nano-polyplexes against ovarian cancer.Colloids Surf B Biointerfaces2022https://conductscience.org/library/papers/35994990PubMed
2027585998Solubility enhancement and targeted delivery of a potent anticancer flavonoid analogue to cancer cells using ligand decorated dendrimer nano-architectures.J Colloid Interface Sci2016https://conductscience.org/library/papers/27585998PubMed

See all 151 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.

PMIDTitleJournalYearIn PapersSource
42619255Mitochondria-Targeted Nanotherapies in Aging Neurodegenerative Disorders: Emerging Prospects and Clinical Potential.Adv Healthc Mater2026https://conductscience.org/library/papers/42619255PubMed
42545462QSAR modeling and in vitro studies of the selective action of triphenylphosphonium salts as anticancer agents against the rhabdomyosarcoma cell line.Med Chem Res2026https://conductscience.org/library/papers/42545462PubMed
42348102The linker governs the organelle targeting of TPP⁺-modified zinc phthalocyanine photosensitizers.Photochem Photobiol Sci2026https://conductscience.org/library/papers/42348102PubMed
42099586Mitochondrial biology and immune crosstalk in breast cancer: therapeutic opportunities and challenges.Front Immunol2026https://conductscience.org/library/papers/42099586PubMed
42094737Nanomaterial-Mediated Targeting of Mitochondrial Metabolism: Strategies and Applications in Cancer Therapy.Int J Nanomedicine2026https://conductscience.org/library/papers/42094737PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40524980

GET https://conductscience.org/api/papers/v1/40524980/references?page=2